These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9498433)

  • 21. Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.
    Englund JA; Raskino C; Vavro C; Palumbo P; Ross LL; McKinney R; Nikolic-Djokic D; Colgrove RC; Baker CJ;
    Pediatr Infect Dis J; 2004 Jan; 23(1):15-22. PubMed ID: 14743040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on nevirapine: quest for a niche.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):37-43. PubMed ID: 11364713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid substitutions at position 69 of the reverse transcriptase of human immunodeficiency virus type 1 are frequent in zalcitabine-naive antiretroviral-drug-experienced patients.
    Montes B; Segondy M
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3110-1. PubMed ID: 12183287
    [No Abstract]   [Full Text] [Related]  

  • 25. Viral phenotype, antiretroviral resistance and clinical evolution in human immunodeficiency virus-infected children.
    Mellado MJ; Cilleruelo MJ; Ortiz M; Villota J; García M; Perez-Jurado ML; Barreiro G; Martín-Fontelos P; Bernal A
    Pediatr Infect Dis J; 1997 Nov; 16(11):1032-7. PubMed ID: 9384335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.
    Tuttle DL; Anders CB; Aquino-De Jesus MJ; Poole PP; Lamers SL; Briggs DR; Pomeroy SM; Alexander L; Peden KW; Andiman WA; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):353-62. PubMed ID: 11897037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3.
    Revicki DA; Swartz C; Wu AW; Haubrich R; Collier AC
    Antivir Ther; 1999; 4(1):35-44. PubMed ID: 10682127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
    Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
    AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of HIV-1 RNA during antiretroviral therapy: association with viral phenotype and development of resistance.
    Katzenstein TL; Nielsen C; Bruun L; Mathiesen LR; Pedersen C; Gerstoft J
    Antivir Ther; 1996 Dec; 1(4):246-54. PubMed ID: 11324827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral neuropathy: zalcitabine reassessed.
    Carey P
    Int J STD AIDS; 2000 Jul; 11(7):417-23. PubMed ID: 10919481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with changes in the use of antiretroviral therapy by a cohort of homosexual men infected with human immunodeficiency virus type 1.
    Park LP; Graham NM; Jacobson LP; Murphy R; Besley D; Zucconi S; Muñoz A
    Clin Infect Dis; 1995 Oct; 21(4):930-7. PubMed ID: 8645842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric HIV infection: a primer for pharmacists.
    Cohen LG; Noormohamed SE
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):580-95. PubMed ID: 8908935
    [No Abstract]   [Full Text] [Related]  

  • 35. Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229.
    Schapiro JM; Lawrence J; Speck R; Winters MA; Efron B; Coombs RW; Collier AC; Merigan TC
    J Infect Dis; 1999 Jan; 179(1):249-53. PubMed ID: 9841849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
    Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
    [No Abstract]   [Full Text] [Related]  

  • 37. Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy.
    Averbuch D; Schapiro JM; Lanier ER; Gradstein S; Gottesman G; Kedem E; Einhorn M; Grisaru-Soen G; Ofir M; Engelhard D; Grossman Z
    Pediatr Infect Dis J; 2006 Nov; 25(11):1049-56. PubMed ID: 17072129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
    Spooner KM; Lane HC; Masur H
    Clin Infect Dis; 1996 Jul; 23(1):15-27. PubMed ID: 8816123
    [No Abstract]   [Full Text] [Related]  

  • 39. Rational approaches to resistance: nucleoside analogues.
    Mayers D
    AIDS; 1996 Nov; 10 Suppl 1():S9-13. PubMed ID: 8970670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
    Reinis M; Vandasová J; Stanková M; Linka M; Brůcková M
    Acta Virol; 2001; 45(5-6):279-86. PubMed ID: 12083326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.